Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 1-10 of 17 (Search time: 0.005 seconds).

  Repaglinide reduces postprandial chylomicron-deficient plasma triglycerides in patients with type 2 diabetes (Journal article)

  Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia (Journal article)

  Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels (Journal article)

  High density lipoprotein changes in patients with microvascular angina (Journal article)

  Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia (Journal article)

  Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia (Journal article)

  PAF-acetylhydrolase activity in familial hypercholesterolaemia (Journal article)

  N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL (Journal article)

  PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro (Journal article)

  Paf-Degrading Acetylhydrolase Is Preferentially Associated with Dense Ldl and Vhdl-1 in Human Plasma - Catalytic Characteristics and Relation to the Monocyte-Derived Enzyme (Journal article)